The NPPA has revised ceiling prices for coronary stents to make life-saving devices more affordable. Hospitals must follow strict pricing rules, display rates, and provide itemised bills, while patients can report overcharging through official channels and mobile apps.
The capsules are under price control as per Drugs (Prices Control) Order, 2013 and the price should be in accordance with the ceiling price fixed by National Pharmaceutical Pricing Authority (NPPA), Government of India.
The antibiotic, Meropenem injection IP 1 g sold under the brand name ‘Donem’ is under price control as per Drugs (Prices Control) Order, 2013 and the price of the product shall be by the ‘Ceiling Price’ fixed by National Pharmaceutical Pricing Authority (NPPA), Government of India.
The price monitoring and resource unit (PMRU) will function at the state level under the direct supervision of the state drug controller for increasing outreach of the NPPA
